# Leuprolide acetate therapy in LH-dependent Cushing's syndrome: in vivo and in vitro observations.

> PubMed lists PMID 15685898 in The Netherlands journal of medicine as Case Reports, Journal Article, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-15685898-leuprolide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15685898-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15685898-leuprolide-v1.json
- Content SHA-256: `d8c379831c5d9e2bf8d81f467d1fa6dd31d9436d96994afc57349fac2c7f3b4a`

## Claims and source pins

### Headline

Leuprolide acetate therapy in LH-dependent Cushing's syndrome: in vivo and in vitro observations. ([`pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798`](#source-pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798))

### Summary

PubMed lists PMID 15685898 in The Netherlands journal of medicine as Case Reports, Journal Article, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798`](#source-pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798))

### Paragraph 1

PubMed lists PMID 15685898 in The Netherlands journal of medicine as Case Reports, Journal Article, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798`](#source-pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798`](#source-pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798))

## Sources

<a id="source-pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798"></a>
- **Leuprolide acetate therapy in LH-dependent Cushing's syndrome: in vivo and in vitro observations. · retained source version 1:2013-11-21:current:7317a09b57987c88642c99ee6106559e619fe7cb4297d1357526853a11180d81** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15685898/) (`pubmed-observation-pmid-15685898-2013-11-21-7317a09b5798`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Leuprolide acetate therapy in LH-dependent Cushing's syndrome: in vivo and in vitro observations." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15685898-leuprolide-v1.json SHA-256: d8c379831c5d9e2bf8d81f467d1fa6dd31d9436d96994afc57349fac2c7f3b4a.